Efficacy of immune ‐checkpoint inhibitors in metastatic gastric or gastroesophageal junction adenocarcinoma by patient subgroups: A systematic review and meta‐analysis

ConclusionsCompared to standard treatment, ICIs in metastatic gastric/GEJ adenocarcinoma did not improve OS. None of the evaluated subgroups has shown increased magnitude of effect to ICIs, aside of the small group with MSI ‐H tumors.

Source: Cancer Medicine - August 31, 2020 Category: Cancer & Oncology Authors: Yulia Kundel, Michal Sternschuss, Assaf Moore, Gali Perl, Baruch Brenner, Hadar Goldvaser Tags: ORIGINAL RESEARCH Source Type: research